Concepedia

Publication | Open Access

Serum PARC/CCL-18 Concentrations and Health Outcomes in Chronic Obstructive Pulmonary Disease

DOIFull Paper Access

114

Citations

23

References

2011

Year

Don D. Sin, Bruce E. Miller, Annelyse Duvoix, S. F. Paul Man, Xuekui Zhang, Edwin K. Silverman, John E. Connett, N. Anthonisen, Robert A. Wise, Donald P. Tashkin,
American Journal of Respiratory and Critical Care Medicine

Abstract

Serum PARC/CCL-18 levels are elevated in COPD and track clinical outcomes. PARC/CCL-18, a lung-predominant chemokine, could be a useful blood biomarker in COPD.

References

YearCitations

Page 1